Home > PJ (current issue) > Leading article | Search

PJ Online homeThe Pharmaceutical Journal
Vol 279 No 7474 p424
20 October 2007

This article
Reprint   Photocopy

PDF 25K, Acrobat Reader

Leading Article

Obesity is the new smoking

Five years ago, obesity and people who were overweight cost the UK just under £7bn in terms of treatment, state benefits, loss of earnings and reduced productivity. In 40 years’ time, that figure could increase by 900 per cent. So concludes the largest ever UK study into obesity, led by Sir David King, the Government’s chief scientific adviser, and involving 250 experts. Obesity, the researchers conclude, is an inevitable consequence of a society in which energy-rich, cheap foods, labour-saving devices, accessible transport and sedentary work are the norm. The idea that obesity is simply a product of greed is outmoded.

The parallels with smoking are striking. About 40 to 50 years ago, the consequences of smoking on health were beginning to be understood. The first two major reports on the dangers of smoking were published by the Royal College of Physicians in 1962 and 1971. Gradually the pressure has increased with ever more dire warnings being printed on packs, hikes in tax, bans on advertising and the development of medicines to help quitters succeed. The greatest deterrent, arguably, has been peer-group pressure: fewer middle class, middle-aged people smoke than socially disadvantaged groups, where smoking remains common. That works both ways: young people of all backgrounds start smoking to appear “cool” — despite knowing the dangers.

In five or so years’ time, obesity is likely to be treated in a similar way: educated people will become fattists and being obese will become socially unacceptable. Changes in attitude may not have the same impact on low-income groups, who are likely to be excluded from the benefits of healthy diets for longer.

Public health minister Dawn Primarolo has said it is too early to say whether the approach seen against smoking would be adopted with obesity, including levying a tax on fatty foods.

If the Government is sensible, it will move fast, clamp down on the food industry and start focusing on children from birth. However, there is a real possibility that the battle may already have been lost. Jamie Oliver’s attempts to re-educate children’s palates have been patchy. In parts of the country his initiative was welcomed but, overall, 400,000 fewer children in secondary schools now take school meals than did before his campaign to improve them was launched — a drop of 20 per cent.

As in smoking cessation, pharmacists should have a part to play, but for obesity interventions to be effective and lead to sustainable changes in behaviour they may need to be far more drastic than yet imagined.

Back to Top


©The Pharmaceutical Journal